FSTL4: A Potential Drug Target and Biomarker (G23105)
FSTL4: A Potential Drug Target and Biomarker
Follistatin-related protein 4 (FSTL4) is a protein that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. FSTL4 is a member of the follistatin gene family, which encodes a family of proteins that have been shown to play a variety of roles in cellular processes, including DNA replication, gene expression, and cell signaling.
Recent studies have identified FSTL4 as a potential drug target due to its involvement in several cellular processes that are associated with the development and progression of various diseases. For example, FSTL4 has been shown to be involved in the regulation of cell proliferation, differentiation, and survival, and has been linked to the development of cancer. Additionally, FSTL4 has been shown to play a role in the development of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.
FSTL4 has also been identified as a potential biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that FSTL4 levels are often elevated in cancer cells, and that reducing FSTL4 levels can lead to the inhibition of cancer cell growth and the development of a more aggressive cancer phenotype. Additionally, FSTL4 has been shown to be involved in the development of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease, and has been linked to the progression of these diseases.
In addition to its potential drug target and biomarker properties, FSTL4 has also been shown to have a variety of biological functions that are important for human health. For example, FSTL4 has been shown to play a role in the regulation of cell signaling pathways, including the TGF-β pathway, which is involved in the development and maintenance of tissues and organs. Additionally, FSTL4 has been shown to play a role in the regulation of cellular processes that are important for embryonic development and normal tissue growth, such as the development of tissues and organs during fetal development.
Overall, FSTL4 is a protein that has the potential to be a drug target and biomarker for a variety of diseases. Further research is needed to fully understand the role of FSTL4 in these diseases and to develop effective treatments.
Protein Name: Follistatin Like 4
More Common Targets
FSTL5 | FTCD | FTCDNL1 | FTH1 | FTH1P1 | FTH1P10 | FTH1P11 | FTH1P12 | FTH1P2 | FTH1P20 | FTH1P22 | FTH1P24 | FTH1P3 | FTH1P4 | FTH1P5 | FTH1P7 | FTH1P8 | FTHL17 | FTL | FTLP16 | FTLP2 | FTLP3 | FTLP7 | FTMT | FTO | FTO-IT1 | FTOP1 | FTSJ1 | FTSJ3 | FTX | FUBP1 | FUBP3 | FUCA1 | FUCA2 | Fucosyl GM1 | Fucosyltransferase | FUNDC1 | FUNDC2 | FUNDC2P2 | FUNDC2P3 | FUOM | FURIN | FUS | FUT1 | FUT10 | FUT11 | FUT2 | FUT3 | FUT4 | FUT5 | FUT6 | FUT7 | FUT8 | FUT8-AS1 | FUT9 | FUZ | FXN | FXR1 | FXR2 | FXYD1 | FXYD2 | FXYD3 | FXYD4 | FXYD5 | FXYD6 | FXYD6-FXYD2 | FXYD7 | FYB1 | FYB2 | FYCO1 | FYN | FYTTD1 | FZD1 | FZD10 | FZD10-AS1 | FZD2 | FZD3 | FZD4 | FZD4-DT | FZD5 | FZD6 | FZD7 | FZD8 | FZD9 | FZR1 | G protein-Coupled Inwardly-Rectifying Potassium Channel (GIRK) | G Protein-Coupled Receptor Kinases (GRKs) | G0S2 | G2E3 | G2E3-AS1 | G3BP1 | G3BP2 | G6PC1 | G6PC2 | G6PC3 | G6PD | GA-binding protein | GAA | GAB1 | GAB2
